Journal of Neuroimmunology

Papers
(The TQCC of Journal of Neuroimmunology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Editorial Board138
MicroRNAs are dysregulated in peripheral blood mononuclear cells in multiple sclerosis and correlate with T cell mediators93
Lymphomas mimicking neuroinflammatory diseases – A diagnostic conundrum worth revisiting90
Ursolic acid enhances social behavior and modulates Th1, Th17, and T regulatory cell-related transcription factor signaling in the BTBR T+ Itpr3tf/J mouse model of autism72
Mononuclear phagocytes in blood and cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis: Untreated and treated with anti-CD20 therapy68
Soluble c-Met correlates with NfL and GFAP levels in the CSF of patients with multiple sclerosis56
Effect of pharmacological intervention and pathogenesis discussion about rats with tic disorders51
A complex and severe encephalitis associated with four co-existing neuronal cell-surface autoantibodies30
Autoimmune cerebellar ataxia associated with anti-leucine-rich glioma-inactivated protein 1 antibodies: Two pediatric cases29
Cytokine profile and brain biopsy in a case of childhood-onset central nervous system vasculitis in Noonan syndrome-like disorder due to a novel CBL variant27
Stiff person syndrome spectrum disorders; more than meets the eye27
Microglial-mediated immune mechanisms in autoimmune uveitis: Elucidating pathogenic pathways and targeted therapeutics26
The role of damage associated molecular pattern molecules (DAMPs) and permeability of the blood-brain barrier in depression and neuroinflammation25
Nicotine is an Immunosuppressant: Implications for Women's Health and Disease24
Genome-wide identification of murine interferon genes in microglial-mediated neuroinflammation in Alzheimer's disease24
An updated, comprehensive meta-analysis of the treatment of anti-NMDAR encephalitis: Analysis, equipoise, and the urgent need for evidence over anecdote24
Serum from Myalgic encephalomyelitis/chronic fatigue syndrome patients causes loss of coherence in cellular circadian rhythms24
Letter to the Editor Regarding “Spinocerebellar ataxia masquerading as multiple sclerosis, a case report”23
Microscopic Polyangiitis With a Twist: A Rare Case of CRAO and Brainstem Infarction22
Occult cartilaginous choristoma in a child with myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis22
Editorial Board22
Sjogren's syndrome meets Meige's syndrome22
Cladribine treatment for highly active multiple sclerosis: Real-world clinical outcomes for years 3 and 421
Treatment with sofosbuvir attenuates the adverse neurodevelopmental consequences of Zika virus infection in infant rhesus macaques21
Low vitamin D status is associated with inflammatory response in older patients with cerebral small vessel disease20
Characterizing double seronegative neuromyelitis optica spectrum disorder: A distinct subgroup or part of the continuum?20
Associations between serum levels of alpha-calcitonin gene-related peptide and clinical features of neuromyelitis optica spectrum disorders20
Free light chains as a reliable biomarker of intrathecal synthesis in the diagnosis of CNS inflammatory diseases20
Unilateral cortical autoimmune encephalitis: A case series and comparison to late-onset Rasmussen's encephalitis20
A rare cause of visual impairment in patients with multiple sclerosis: Uveitis19
Prognostic significance of PD-L1 and CD45RO+ cells in glioblastoma: The modulating role of MMR status19
Clinical characteristics of autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy in children: A case series of 16 patients19
Neuromyelitis optica spectrum disorder mimicking stroke: A case report and literature review18
Neuroinflammation and schizophrenia: The role of Toxoplasma gondii infection and astrocytic dysfunction18
Sexual dimorphism of hypothalamic serotonin release during systemic inflammation: Role of endothelin-117
Characteristics and prognosis of PCA-1 (anti-Yo) autoimmunity and the utility of the Brief Ataxia Rating Scale in a seropositive cerebellar ataxia cohort16
Whole blood miRNAs in relapsing MS patients treated with dimethyl fumarate in the phase 4 TREMEND trial16
Editorial Board16
Metalloproteinase imbalance in HIV-1: Subtype comparison in CSF and serum16
HMGB1/TLR4 axis promotes pyroptosis after ICH by activating the NLRP3 inflammasome16
Immature ovarian teratomas in anti-NMDA receptor encephalitis16
Editorial Board15
Anti-N-methyl-d-aspartate receptor encephalitis preceded by meningitis lasting up to 60 days15
In memoriam: Jennifer L. Stark, PhD15
A 7-year-old with new-onset seizures, behavior disturbance, and encephalitis15
Atypical clinical and novel radiological findings in Susac syndrome: Experience from a large monocentric cohort15
d-serine prevents cognitive impairment in a mouse model of NMDAR encephalitis14
Characterization of Japanese multiple sclerosis patients with progression independent of relapse activity: A 2-year multicenter cohort study14
Ido1 or Ido2 deficiency in myeloid-derived cells attenuates TMEV-induced ictogenesis14
Using interleukin-18, Eotaxin-1, and Eotaxin-3 to identify brain injury in neonates with congenital heart disease14
Adult-onset neurodegeneration in XMEN disease14
HLA-G*14 bp indel variant in autism spectrum disorder in a population from southern Brazil14
Distinguishing CNS neurosarcoidosis from multiple sclerosis and an approach to “overlap” cases14
Clinico-pathological correlation in unilateral cortical encephalitis treated with tocilizumab after first-line treatment failure14
"Lipopolysaccharide-induced animal models for neuroinflammation – An overview."13
Heightened effector immune cell infiltration of the hippocampus concurrently with brain ventricular volume expansion in aged APP/PS1 mice13
Ferroptosis as a mechanism of oligodendrocyte loss and demyelination in experimental autoimmune encephalomyelitis13
Exosome-transmitted ANGPTL1 suppresses angiogenesis in glioblastoma by inhibiting the VEGFA/VEGFR2/Akt/eNOS pathway13
Identification of PTGS2 as a genetically supported protective biomarker and potential therapeutic target in myasthenia gravis13
Association of interleukins 17A and 22 levels and their common genetic polymorphisms in Guillain Barré syndrome13
Ginkgo biloba extract (EGb-761) confers neuroprotection against ischemic stroke by augmenting autophagic/lysosomal signaling pathway13
Neoehrlichiosis in patients with multiple sclerosis in Halmstad, Sweden: A case series13
Identification of the core genes KLRB1 and RETN as potential shared diagnostic markers for major depressive disorder and systemic lupus erythematosus through bioinformatics and machine learning method12
Elevated serum levels of IL-10 family and IL-12 family cytokines in myasthenia gravis12
Therapeutic potential of Baicalin against experimental obsessive compulsive disorder: Evidence from CSF, blood plasma, and brain analysis12
Effect on disease activity of ofatumumab in the treatment of glial fibrillary acidic protein astrocytopathy and 18F-DPA714 PET/MRI imaging assessment12
Immune profiling unveils the systemic cytokine milieu associated with acute reversible encephalopathy with cytotoxic lesions of the corpus callosum (CLOCCs)12
Recent advances in the treatment of primary and secondary progressive Multiple Sclerosis12
Causal relationships between monocyte chemoattractant protein-1 levels and neuropsychiatric disorders: Evidence from large-scale genetic data12
The pathophysiology of major depressive disorder through the lens of systems biology: Network analysis of the psycho-immune-neuroendocrine physiome12
Early life stress aggravates disease pathogenesis in mice with experimental autoimmune encephalomyelitis: Support for a two-hit hypothesis of multiple sclerosis etiology12
Association of peripheral immune activation with amyotrophic lateral sclerosis and Parkinson's disease: A systematic review and meta-analysis12
A functional role for alpha-synuclein in neuroimmune responses12
Effects of androgen modifying therapies on disease activity in older men with multiple sclerosis11
Chronic g-CSF increases the neutrophil-lymphocyte ratio and decreases plasma corticosterone concentrations in Peromyscus maniculatus without impacting compulsive-like stereotypy11
Autoimmune encephalitis misdiagnosis and mimics11
Functional immune responses to PI3K pathway inhibition in PBMCs from schizophrenia patients without metabolic syndrome11
Circulating levels of inflammatory biomarkers in Huntington's disease: A systematic review and meta-analysis11
Matrine mediated neuroprotective potential in experimental multiple sclerosis: Evidence from CSF, blood markers, brain samples and in-silico investigations11
Painless progressive mononeuritis multiplex secondary to AML associated neuroleukemiosis11
Age and sex-dependent gut alterations in mice induced by neonatal immune activation with lipopolysaccharide10
Editorial Board10
Early-stage volume losses in the corpus callosum and thalamus predict the progression of brain atrophy in patients with multiple sclerosis10
Are corneal nerve and dendritic cell parameters assessed via corneal confocal microscopy good markers for multiple sclerosis? – A systematic review and meta-analysis10
Effects of a high saturated fatty acid diet on the intestinal microbiota modification and associated impacts on Parkinson's disease development10
Iatrogenic NORSE: Immune checkpoint inhibitor-related anti-GFAP autoimmune astrocytopathy10
Immunological heterogeneity in Ménière's disease: CD4+ T cell subset profiling reveals three distinct Immunophenotypes10
Editorial Board10
Wearable-based physiological monitoring and brain magnetic resonance imaging metrics in multiple sclerosis: A feasibility study10
The role of TREM1 in regulating microglial polarization in sevoflurane-induced perioperative neurocognitive disorders10
3D imaging and pathological analysis of microglia in LPS-treated mice with light-sheet fluorescence microscopy10
Impact of blood-brain barrier disruption on clinical features and treatment response in patients with newly diagnosed autoimmune encephalitis10
SPI1 affects Aβ1–42-induced microglia-mediated neuroinflammation by transcriptionally regulating FOSL2 expression10
Minocycline inhibits microglial activation in the CA1 hippocampal region and prevents long-term cognitive sequel after experimental cerebral malaria10
Glial changes in the dentate gyrus of neuronal-specific PTEN knockout mice correlate with changes in cell proliferation10
Macrophage-derived exosomes exacerbate postoperative cognitive dysfunction in mice through inflammation10
The role of the immune system in Parkinson's disease pathogenesis: A focus on Th17 cells - A systematic review and meta-analysis10
Monoclonal antibody efficacy in seropositive vs seronegative NMOSD: systematic review and meta-analysis10
Genetic deletion of c-Jun amino-terminal kinase 3 (JNK3) modestly increases disease severity in a mouse model of multiple sclerosis10
Peripheral and central inflammation in depression: How large is the gap and can we bridge it with PET neuroimaging and neural-derived extracellular vesicles?10
Novel biomarkers and interferon signature in secondary progressive multiple sclerosis9
Cerebral amyloid angiopathy-related inflammation superimposed on alpha-synucleinopathies: a case report and literature review9
Short-chain fatty acids, neuroinflammation, and autism spectrum disorders: A mechanistic systematic review9
Editorial Board9
Geraniol (GER) attenuated chronic sleep restriction (CSR)-induced neuroinflammation in adolescent mice9
Neuro-Sjögren: A clinical-radiological paradox affecting the central nervous system9
Elevated serum levels of C-terminal agrin fragment in acetylcholine receptor antibody-positive myasthenia gravis9
Maresin1 improves postoperative delirium-like behavior in mice with tibial fractures by inhibiting the TLR4/MyD88/NF-kB pathway9
Anti-Lactosylceramide antibody positive combined central peripheral demyelination emerging from long-standing juvenile-onset chronic inflammatory polyradiculoneuropathy; a report of two cases9
The therapeutic effect of ofatumumab in autoimmune encephalitis: A case series9
TMEM132A autoimmunity in patients with suspected autoimmune cerebellar ataxia9
Editorial Board9
Bioinformatics exploration of SPHKAP's role in IDH-mutant glioma involving energy metabolism, prognosis, and immune modulation9
An enjoyable career in science9
Human dendritic cell subsets in the glioblastoma-associated microenvironment9
Apathy in autoimmune GFAP Astrocytopathy: A case series and literature review9
Cadmium exposure exacerbates immunological abnormalities in a BTBR T+ Itpr3tf/J autistic mouse model by upregulating inflammatory mediators in CD45R-expressing cells9
Calcitriol modulate post-ischemic TLR signaling pathway in ischemic stroke patients9
Analysis of risk factors for a poor functional prognosis and relapse in patients with autoimmune encephalitis9
Plasma TNF-α and phosphorylated α-syn are associated with fatigue in patients with Parkinson's disease9
Safety and efficacy of intrathecal rituximab in refractory neuroimmune disorders- a case series9
The medulla oblongata shows a sex-specific inflammatory response to systemic neonatal lipopolysaccharide9
Syringic acid suppresses inflammation by upregulation of SOCS39
Editorial Board9
Neuromodulator hydrogen sulfide attenuates sickness behavior induced by lipopolysaccharide9
Bridging the triad: A comprehensive review of Susac's syndrome9
Discordance of reported multiple sclerosis clinical course amongst patients and providers9
Autoantibody-mediated disorders of the central and peripheral nervous system9
Viral co-infection, autoimmunity, and CSF HIV antibody profiles in HIV central nervous system escape8
Diversity of childhood-onset myasthenia gravis: pathophysiology and treatment8
B cell tolerance checkpoint function in multiple sclerosis and transient CD52 depletion8
The real-world experience of biologics for neuromyelitis optica spectrum disorders as first-line and switched therapy8
Neuronal inflammation-associated biomarkers in cerebrospinal fluid of patients with acute and chronic inflammatory demyelinating polyneuropathies8
Predictors from systemic and neuro-inflammation in amyotrophic lateral sclerosis: A monocentric experience8
Fibrinolysis associated proteins and lipopolysaccharide bioactivity in plasma and cerebrospinal fluid in multiple sclerosis8
Granagard administration prolongs the survival of human mesenchymal stem cells transplanted into a mouse model of multiple sclerosis8
Free light chains analysis in cerebrospinal fluid for the diagnosis of multiple sclerosis: A study in the Israeli population8
Brain tumor detection using HyGSNet and feature extraction with DWT-based GDP8
Cerebrospinal fluid soluble CD27 is associated with CD8+ T cells, B cells and biomarkers of B cell activity in relapsing-remitting multiple sclerosis8
Myeloid cell heterogeneity in the tumor microenvironment and therapeutic implications for childhood central nervous system (CNS) tumors8
Wash-out duration and lymphocyte count in switching from fingolimod to ofatumumab: A case report and literature review8
Normocomplementemic urticarial vasculitis in a patient with multiple sclerosis on glatiramer acetate8
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: Presentation and outcomes of adults at a single center7
Real-world experience with switching from intravenous immunoglobulin to subcutaneous efgartigimod PH20 in patients with chronic inflammatory demyelinating polyradiculoneuropathy: A case series7
Structural and functional biomarkers of visual dysfunction in MOG antibody-positive optic neuritis: a scoping review7
When gut and nerves collide: A case of Neuromyelitis Optica Spectrum disorder after golimumab for ulcerative colitis7
Autoantigen and IL-2 activated CD4+CD25+T regulatory cells are induced to express CD8 and are autoantigen specific in inhibiting experimental autoimmune encephalomyelitis7
Prolonged STAT1 activation in neurons drives a pathological transcriptional response7
Gut dysbiosis influences the pathophysiology of multiple sclerosis: A case-control study from North India7
Interleukin-17 is involved in neuropathic pain and spinal synapse plasticity on mice7
Caveolin-1 mediates blood-brain barrier permeability, neuroinflammation, and cognitive impairment in SARS-CoV-2 infection7
Local immunotherapy of glioblastoma: A comprehensive review of the concept7
Inherited chromosomally-integrated human herpes virus 6 confounding test results in a patient with myelitis and optic neuritis – A case report7
Exploring the causal role of immune cells in vascular dementia: A bidirectional mendelian randomization study7
Bergapten inhibiting NLRP3 inflammasome activation and pyroptosis to alleviate neuropathic pain in a rat mode of chronic constriction injury7
Editorial Board7
The PTEN-associated immune prognostic signature reveals the landscape of the tumor microenvironment in glioblastoma7
Endothelial dysfunction in neurodegenerative disease: Is endothelial inflammation an overlooked druggable target?7
MINI-review of Epstein-Barr virus involvement in multiple sclerosis etiology and pathogenesis7
Aggressive MOGAD with bilateral corticospinal tract lesions following infection with Jamestown Canyon virus7
A three-compartment apparatus alters the brain concentration of cytokines and neurotrophic factors in cocaine-induced CPP in mice7
Editorial Board7
Disordered gut microbiota and changes in short-chain fatty acids and inflammatory processes in stress-vulnerable mice7
Comparison of prednisolone monotherapy vs. tacrolimus combination in NMOSD: Efficacy, safety, and optimal therapeutic timing7
miR-92a-3p regulates neuropathic pain and neuroinflammation by regulating the expression of WNT5A7
Exploring the role of the IL-12/IFN-γ immune axis in subacute sclerosing panencephalitis7
Presumptive isolated neurosarcoidosis involving eloquent structures: An argument for empirical TNF-α inhibition7
Ocrevus reduces TH40 cells, a biomarker of systemic inflammation, in relapsing multiple sclerosis (RMS) and in progressive multiple sclerosis (PMS)7
Self-delivering mRNA inhibitors of MK2 improve outcomes after spinal cord injury7
Kidney injury: An overlooked manifestation in autoimmune encephalitis6
Clinical features and outcomes of patients with muscle-specific kinase antibody-positive myasthenia gravis in Japan6
Migration timeframe of germinal center-derived B cells to the central nervous system during viral encephalomyelitis6
Efficacy and tolerability of metformin as an adjuvant therapy in patients with relapse-remitting multiple sclerosis receiving interferon Beta 1a: A randomized pilot trial6
The case report of AQP4 and MOG IgG double positive NMOSD treated with subcutaneous Ofatumumab6
Fluorescence-detection size-exclusion chromatography specifically detects autoantibodies targeting the ganglionic acetylcholine receptor in patients with autoimmune autonomic ganglionopathy6
Double hit – A case in point for dual seropositivity to AQP4 and MOG antibodies6
Brain tumor classification using hybrid spinal-EfficientNet using MRI images6
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): Practical recommendations for diagnosis and management6
Association of thyroid autoimmune status with Alzheimer’s disease biomarkers in euthyroid subjects6
Chronic stress disrupts Th17/Treg balance to induce depressive-like behaviors: Preclinical and clinical evidence6
Germinal centers are associated with poor prognosis in patients with thymoma-associated myasthenia gravis6
Exogenous IL-33 mitigates inflammatory responses by suppressing the NF-Κb signaling pathway, promoting blood-spinal cord barrier repair and neural functional recovery6
Carbon monoxide and anti-amyloid-β combination therapy modulates miR-381 and molecular biomarkers in an aluminum chloride–induced rat model of Alzheimer's disease6
Characterizing the relationship between FLAIR hyper-rim lesions and paramagnetic rim lesions in multiple sclerosis6
Editorial Update6
Guhong injection attenuates brain injury and promotes neuroprotection after acute ischemic stroke6
Comparison of SIMOA and VEUS technologies for serum glial fibrillary acidic protein measurement6
Longitudinal MuSK antibody levels may correlate with disease severity in MuSK myasthenia gravis6
Editorial Board6
IT-DEX and B cell depletion in a child with anti-GAD 65 autoimmune encephalitis presenting as NORSE: A case report6
Weight-drop model as a valuable tool to study potential neurobiological processes underlying behavioral and cognitive changes secondary to mild traumatic brain injury6
The effect of immunosuppression or thymectomy on the response to tetanus revaccination in myasthenia gravis6
3D in vitro modelling of human patient microglia: A focus on clinical translation and drug development in neurodegenerative diseases6
Corrigendum to “MP4- and MOG:35–55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum” [J Neuroimmunol 189(1–2) (2007) 31–40]6
Immunostimulatory and immunomodulatory effects of duloxetine and venlafaxine on p38 MAPK and PI3K pathways6
Effect of the sEH inhibitor AUDA on arachidonic acid metabolism and NF-κB signaling of rats with postpartum depression-like behavior6
Platelets bridging the gap between gut dysbiosis and neuroinflammation in stress-linked disorders: A narrative review6
Possible risk of rheumatoid arthritis treated with methotrexate to the central nervous system relapse of diffuse large B-cell lymphoma6
0.79162406921387